VANGUARD GROUP INC 13D and 13G filings for Bellicum Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-09 11:07 am Sale | 2022-12-30 | 13G | Bellicum Pharmaceuticals, Inc. BLCM | VANGUARD GROUP INC | 181,843 2.110% | -248,235 (-57.72%) | Filing |
| 2022-02-09 3:24 pm Purchase | 2021-12-31 | 13G | Bellicum Pharmaceuticals, Inc. BLCM | VANGUARD GROUP INC | 430,078 5.120% | 430,078 (New Position) | Filing |